Ascentage Pharma Group International (AAPG) Other Gross PP&E Adjustments (2023 - 2025)
Ascentage Pharma Group International posted quarterly Other Gross PP&E Adjustments of -$6.7 million for Q4 2025, up 13.67% year-on-year from -$5.9 million in Q4 2024, and up 3.91% on a QoQ basis from -$7.0 million in Q2 2025.
Ascentage Pharma Group International (AAPG) has 3 years of Other Gross PP&E Adjustments data on file, last reported at -$6.7 million in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 13.67% year-over-year to -$6.7 million; the trailing twelve-month figure through Dec 2025 stood at -$6.7 million (up 13.67% YoY), and the FY2025 full-year result was -$6.7 million, up 14.8% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$6.7 million, up from -$7.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$6.7 million in Q4 2025 and bottomed at -$7.8 million in Q4 2024.
- The 3-year median for Other Gross PP&E Adjustments is -$7.1 million (2023), against an average of -$7.2 million.
- The widest annual swing landed in 2024, when Other Gross PP&E Adjustments retreated 9.74%; it then advanced 13.67% in 2025.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at -$7.1 million in 2023, then fell by 9.74% to -$7.8 million in 2024, then rose by 13.67% to -$6.7 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$6.7 million (Q4 2025), -$7.0 million (Q2 2025), and -$7.8 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Ascentage Pharma Group International | 1.11 Bn | 937.28 Mn | - | -6.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.74 Mn |
| Dec 31, 2025 | -6.74 Mn |
| Jun 30, 2025 | -7.02 Mn |
| Jun 30, 2025 | -7.02 Mn |
| Dec 31, 2024 | -7.81 Mn |
| Dec 31, 2024 | -7.81 Mn |
| Dec 31, 2023 | -7.12 Mn |
| Dec 31, 2023 | -7.12 Mn |